Involvement of activating transcription factors JNK;  NF-kappaB;  and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex.

English | 正體中文 | 简体中文 | 全文筆數/總筆數 : 45279/58455 (77%)
造訪人次 : 2491756 線上人數 : 282

RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.

Taipei Medical University Institutional Repository > 醫學科技學院 > 醫學檢驗暨生物技術學系所 > 期刊論文 > Item 987654321/3768

請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/3768

題名:	Involvement of activating transcription factors JNK;NF-kappaB;and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex.
作者:	梁有志 Chen SH;Lin JK;Liang YC;Pan MH;Liu SH;Lin-Shiau SY
貢獻者:	醫學檢驗暨生物技術學系
關鍵詞:	PDTC;copper;oxidative stress;JNK;NF-kappa B;AP-1;caspase;apoptosis;BCPS
日期:	2008
上傳時間:	2009-08-25 10:38:35 (UTC+8)
摘要:	Pyrrolidine dithiocarbamate (PDTC) is a metal chelator. Biologically, slight toxic affects EC50, 100±5.9 μM are observed when added to cultured HL-60 cells. CuCl2 at a physiological concentration (1 μM), but not FeCl2, Pb potentiated the cytotoxic effect of PDTC by 700 fold (EC50, 0.14±0.02 μM). Furthermore, results indicated that the PDTC/Cu complex induced an apoptotic process, evidenced by apoptotic bodies, DNA ladder and hypodiploidy cells. Additional studies showed that PDTC/Cu complex significantly decreased mitochondrial membrane potential, increased cytochrome c release, and reactive oxygen species production, and depleted reduced non-protein thiols in a time-dependent manner. Following oxidative stress, the PDTC/Cu complex sequentially activated JNK, NF-κB and AP-1 signaling pathways while IκB kinase activity was enhanced. The apoptotic process was eventually induced by caspase 3 activation and PARP degradation. The non-permeable copper-specific chelator-bathocuproine disulfonate (BCPS) and vitamin C were able to inhibit apoptosis and the elevation of intracellular Cu. Based on these findings; we conclude that PDTC/Cu complex-induced apoptosis is mediated by activation of JNK, NF-κB, AP-1 and caspase 3. Due to its high potency, PDTC may be useful as a therapeutic anti-cancer drug.
關聯:	Eur J Pharmacol.(594):9-17.
資料類型:	article
顯示於類別:	[醫學檢驗暨生物技術學系所] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
全文.txt		0Kb	Text	305	檢視/開啟
摘要.pdf		35Kb	Adobe PDF	76	檢視/開啟

在TMUIR中所有的資料項目都受到原著作權保護.

TAIR相關文章

著作權聲明 Copyright Notice

本平台之數位內容為臺北醫學大學所收錄之機構典藏，包含體系內各式學術著作及學術產出。秉持開放取用的精神，提供使用者進行資料檢索、下載與取用，惟仍請適度、合理地於合法範圍內使用本平台之內容，以尊重著作權人之權益。商業上之利用，請先取得著作權人之授權。
The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.
瀏覽或使用本平台，視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例，並不得為任何不法目的使用TMUIR。
By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.
本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者，煩請權利人通知本平台維護人員([email protected])，將立即採取移除該數位著作等補救措施。
TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

資料載入中.....